Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anna Rostedt Punga

Showing results (81-90 of 83) with videos related to

Pageof 9
Sort By:
You have reached the last page of results.This site can display upto 83 results.
JAMA Neurology|September 19, 2022
Efficacy and Safety of Rituximab for New-Onset Generalized Myasthenia Gravis: The RINOMAX Randomized Clinical TrialFredrik Piehl, Ann Eriksson-Dufva, Anna Budzianowska, et al.
European Journal of Neurology|November 6, 2025
Rituximab in New-Onset Generalized Myasthenia Gravis: Long-Term Follow-Up of the RINOMAX Clinical TrialJing Wu, Ann Eriksson-Dufva, Anna Budzianowska, et al.
Journal of Neuroimmunology|October 14, 2022
Enrichment of serum IgG4 in MuSK myasthenia gravis patientsDana L E Vergoossen, Annabel M Ruiter, Kevin R Keene, et al.
Pageof 9

Showing results (81-90 of 83) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 83 results.
JAMA Neurology|September 19, 2022
Efficacy and Safety of Rituximab for New-Onset Generalized Myasthenia Gravis: The RINOMAX Randomized Clinical TrialFredrik Piehl, Ann Eriksson-Dufva, Anna Budzianowska, et al.
European Journal of Neurology|November 6, 2025
Rituximab in New-Onset Generalized Myasthenia Gravis: Long-Term Follow-Up of the RINOMAX Clinical TrialJing Wu, Ann Eriksson-Dufva, Anna Budzianowska, et al.
Journal of Neuroimmunology|October 14, 2022
Enrichment of serum IgG4 in MuSK myasthenia gravis patientsDana L E Vergoossen, Annabel M Ruiter, Kevin R Keene, et al.
Pageof 9